Citations (76)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (12)
Ali Arab & Sara Mostafalou. (2022) Neurotoxicity of pesticides in the context of CNS chronic diseases. International Journal of Environmental Health Research 32:12, pages 2718-2755.
Read now
Read now
Dongqing Gu, Shan Ou, Mingshuang Tang, Zhiyong Yin, Zhengguo Wang & Guodong Liu. (2021) Trauma and amyotrophic lateral sclerosis: a systematic review and meta-analysis. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 22:3-4, pages 170-185.
Read now
Read now
Malcolm Proudfoot, Ashley Jones, Kevin Talbot, Ammar Al-Chalabi & Martin R. Turner. (2016) The ALSFRS as an outcome measure in therapeutic trials and its relationship to symptom onset. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 17:5-6, pages 414-425.
Read now
Read now
Torsten Hothorn & Hans H. Jung. (2014) RandomForest4Life: A Random Forest for predicting ALS disease progression. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 15:5-6, pages 444-452.
Read now
Read now
Ettore Beghi. (2013) Are professional soccer players at higher risk for ALS?. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration 14:7-8, pages 501-506.
Read now
Read now
Ali Jawaid, Santosh B. Murthy, Andrew M. Wilson, Salah U. Qureshi, Moath J. Amro, Michael Wheaton, Ericka Simpson, Yadollah Harati, Adriana M. Strutt, Michele K. York & Paul E. Schulz. (2010) A decrease in body mass index is associated with faster progression of motor symptoms and shorter survival in ALS. Amyotrophic Lateral Sclerosis 11:6, pages 542-548.
Read now
Read now
Nicola Vanacore, Pierluigi Cocco, Domenica Fadda & Mustafa Dosemeci. (2010) Job strain, hypoxia and risk of amyotrophic lateral sclerosis: Results from a death certificate study. Amyotrophic Lateral Sclerosis 11:5, pages 430-434.
Read now
Read now
Ceryl A. Harwood, Christopher J. McDermott & Pamela J. Shaw. (2009) Physical activity as an exogenous risk factor in motor neuron disease (MND): A review of the evidence. Amyotrophic Lateral Sclerosis 10:4, pages 191-204.
Read now
Read now
Muddasir Qureshi, Amy Shui, Allitia B. Dibernardo, Robert H. Brown$suffix/text()$suffix/text(), David A. Schoenfeld & Merit E. Cudkowicz. (2008) Medications and laboratory parameters as prognostic factors in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis 9:6, pages 369-374.
Read now
Read now
Lorne Zinman, Reza Sadeghi, Marek Gawel, Dan Patton & Alex Kiss. (2008) Are statin medications safe in patients with ALS?. Amyotrophic Lateral Sclerosis 9:4, pages 223-228.
Read now
Read now
Thomas G. Day, Martin Scott, Roslyn Perring & Pat Doyle. (2007) Motor neuron disease mortality in Great Britain continues to rise: Examination of mortality rates 1975 – 2004. Amyotrophic Lateral Sclerosis 8:6, pages 337-342.
Read now
Read now
Juan Gil, Pierre‐Marie Preux, Ahmadou Alioum, Carlos Ketzoian, Jean‐Claude Desport, Michel Druet‐Cabanac & Philippe Couratier. (2007) Disease progression and survival in ALS: First multi‐state model approach. Amyotrophic Lateral Sclerosis 8:4, pages 224-229.
Read now
Read now
Articles from other publishers (64)
Daniel Saucier, Pierre Philippe Wilson Registe, Mathieu Bélanger & Colleen O'Connell. (2023) Urbanization, air pollution, and water pollution: Identification of potential environmental risk factors associated with amyotrophic lateral sclerosis using systematic reviews. Frontiers in Neurology 14.
Crossref
Crossref
Marziye Eshghi, Yana Yunusova, Kathryn P. Connaghan, Bridget J. Perry, Marc F. Maffei, James D. Berry, Lorne Zinman, Sanjay Kalra, Lawrence Korngut, Angela Genge, Annie Dionne & Jordan R. Green. (2022) Rate of speech decline in individuals with amyotrophic lateral sclerosis. Scientific Reports 12:1.
Crossref
Crossref
Marc G Weisskopf, Joseph Levy, Aisha S Dickerson, Sabrina Paganoni & Maya Leventer-Roberts. (2022) Statin Medications and Amyotrophic Lateral Sclerosis Incidence and Mortality. American Journal of Epidemiology 191:7, pages 1248-1257.
Crossref
Crossref
Ann Logan, Zsuzsanna Nagy, Nicholas M. Barnes, Antonio Belli, Valentina Di Pietro, Barbara Tavazzi, Giuseppe Lazzarino, Giacomo Lazzarino, Lars Bruce & Lennart I. Persson. (2022) A phase II open label clinical study of the safety, tolerability and efficacy of ILB® for Amyotrophic Lateral Sclerosis. PLOS ONE 17:5, pages e0267183.
Crossref
Crossref
Alisa T. Apreleva Kolomeytseva, Lev Brylev, Marziye Eshghi, Zhanna Bottaeva, Jufen Zhang, Jörg C. Fachner & Alexander J. Street. (2022) Home-Based Music Therapy to Support Bulbar and Respiratory Functions of Persons with Early and Mid-Stage Amyotrophic Lateral Sclerosis—Protocol and Results from a Feasibility Study. Brain Sciences 12:4, pages 494.
Crossref
Crossref
Nan Hu, Dongchao Shen, Xunzhe Yang, Liying Cui & Mingsheng Liu. (2022) Plateaus and reversals evaluated by different methods in patients with limb-onset amyotrophic lateral sclerosis. Journal of Clinical Neuroscience 97, pages 93-98.
Crossref
Crossref
Angeline Andrew, Jie Zhou, Jiang Gui, Antoinette Harrison, Xun Shi, Meifang Li, Bart Guetti, Ramaa Nathan, Maeve Tischbein, Erik P. Pioro, Elijah Stommel & Walter Bradley. (2021) Pesticides applied to crops and amyotrophic lateral sclerosis risk in the U.S. NeuroToxicology 87, pages 128-135.
Crossref
Crossref
M. N. Zakharova, I. S. Bakulin & A. A. Abramova. (2021) Toxic Damage to Motor Neurons. Neurochemical Journal 15:4, pages 410-421.
Crossref
Crossref
Guodong Liu, Shan Ou, Huijie Cui, Xuan Li, Zhiyong Yin, Dongqing Gu & Zhengguo Wang. (2021) Head Injury and Amyotrophic Lateral Sclerosis: A Meta-Analysis. Neuroepidemiology 55:1, pages 11-19.
Crossref
Crossref
Hyeon Sik Chu & Juyeon Oh. (2020) Information Needs and Preferences of Family Caregivers of Patients With Amyotrophic Lateral Sclerosis. Journal of Neuroscience Nursing 52:5, pages 207-213.
Crossref
Crossref
Özden O. Dalgıç, F. Safa Erenay, Kalyan S. Pasupathy, Osman Y. Özaltın, Brian A. Crum & Mustafa Y. Sir. (2019) Tollgate-based progression pathways of ALS patients. Journal of Neurology 266:3, pages 755-765.
Crossref
Crossref
Sonja Korner, Johanna Kammeyer, Antonia Zapf, Magdalena Kuzma-Kozakiewicz, Maria Piotrkiewicz, Bożenna Kuraszkiewicz, Hanna Goszczynska, Marta Gromicho, Julian Grosskreutz, Peter M. Andersen, Mamede de Carvalho & Susanne Petri. (2019) Influence of Environment and Lifestyle on Incidence and Progress of Amyotrophic Lateral Sclerosis in A German ALS Population. Aging and disease 10:2, pages 205.
Crossref
Crossref
Mònica Povedano, Marc Saez, Juan-Antonio Martínez-Matos & Maria Antònia Barceló. (2018) Spatial Assessment of the Association between Long-Term Exposure to Environmental Factors and the Occurrence of Amyotrophic Lateral Sclerosis in Catalonia, Spain: A Population-Based Nested Case-Control Study. Neuroepidemiology 51:1-2, pages 33-49.
Crossref
Crossref
Johnathan Cooper-Knock, Claire Green, Gabriel Altschuler, Wenbin Wei, Joanna J. Bury, Paul R. Heath, Matthew Wyles, Catherine Gelsthorpe, J. Robin Highley, Alejandro Lorente-Pons, Tim Beck, Kathryn Doyle, Karel Otero, Bryan Traynor, Janine Kirby, Pamela J. Shaw & Winston Hide. (2017) A data-driven approach links microglia to pathology and prognosis in amyotrophic lateral sclerosis. Acta Neuropathologica Communications 5:1.
Crossref
Crossref
Hongfei Tai, Liying Cui, Dongchao Shen, Dawei Li, Bo Cui & Jia Fang. (2017) Military service and the risk of amyotrophic lateral sclerosis: A meta-analysis. Journal of Clinical Neuroscience 45, pages 337-342.
Crossref
Crossref
John D. Beard, Lawrence S. Engel, David B. Richardson, Marilie D. Gammon, Coleen Baird, David M. Umbach, Kelli D. Allen, Catherine L. Stanwyck, Jean Keller, Dale P. Sandler, Silke Schmidt & Freya Kamel. (2017) Military service, deployments, and exposures in relation to amyotrophic lateral sclerosis survival. PLOS ONE 12:10, pages e0185751.
Crossref
Crossref
Ming-Dong Wang, Julian Little, James Gomes, Neil R. Cashman & Daniel Krewski. (2017) Identification of risk factors associated with onset and progression of amyotrophic lateral sclerosis using systematic review and meta-analysis. NeuroToxicology 61, pages 101-130.
Crossref
Crossref
J. Luna, G. Logroscino, P. Couratier & B. Marin. (2017) Current issues in ALS epidemiology: Variation of ALS occurrence between populations and physical activity as a risk factor. Revue Neurologique 173:5, pages 244-253.
Crossref
Crossref
Sara Mostafalou & Mohammad Abdollahi. (2016) Pesticides: an update of human exposure and toxicity. Archives of Toxicology 91:2, pages 549-599.
Crossref
Crossref
Hannelore K. van der Burgh, Ruben Schmidt, Henk-Jan Westeneng, Marcel A. de Reus, Leonard H. van den Berg & Martijn P. van den Heuvel. (2017) Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis. NeuroImage: Clinical 13, pages 361-369.
Crossref
Crossref
Shashikanta Tarai, Arindam Bit, Helton José dos Reis, András Palotás, Albert Rizvanov & Akalabya Bissoyi. (2016) Stratifying Heterogeneous Dimension of Neurodegenerative Diseases: Intervention for Stipulating Epigenetic Factors to Combat Oxidative Stress in Human Brain. BioNanoScience 6:4, pages 411-422.
Crossref
Crossref
Hazuki Watanabe, Naoki Atsuta, Akihiro Hirakawa, Ryoichi Nakamura, Masahiro Nakatochi, Shinsuke Ishigaki, Aritoshi Iida, Shiro Ikegawa, Michiaki Kubo, Daichi Yokoi, Hirohisa Watanabe, Mizuki Ito, Masahisa Katsuno, Yuishin Izumi, Mitsuya Morita, Kazuaki Kanai, Akira Taniguchi, Ikuko Aiba, Koji Abe, Koichi Mizoguchi, Masaya Oda, Osamu Kano, Koichi Okamoto, Satoshi Kuwabara, Kazuko Hasegawa, Takashi Imai, Akihiro Kawata, Masashi Aoki, Shoji Tsuji, Kenji Nakashima, Ryuji Kaji & Gen Sobue. (2016)
A rapid functional decline type of amyotrophic lateral sclerosis is linked to low expression of
TTN
. Journal of Neurology, Neurosurgery & Psychiatry 87:8, pages 851-858.
Crossref
Crossref
Eleonora Lacorte, Luigina Ferrigno, Emanuele Leoncini, Massimo Corbo, Stefania Boccia & Nicola Vanacore. (2016) Physical activity, and physical activity related to sports, leisure and occupational activity as risk factors for ALS: A systematic review. Neuroscience & Biobehavioral Reviews 66, pages 61-79.
Crossref
Crossref
E.O. Talbott, A.M. Malek & D. Lacomis. 2016. Neuroepidemiology. Neuroepidemiology
225
238
.
Björn Oskarsson, D. Kevin Horton & Hiroshi Mitsumoto. (2015) Potential Environmental Factors in Amyotrophic Lateral Sclerosis. Neurologic Clinics 33:4, pages 877-888.
Crossref
Crossref
Huub Creemers, Hepke Grupstra, Frans Nollet, Leonard H. van den Berg & Anita Beelen. (2014) Prognostic factors for the course of functional status of patients with ALS: a systematic review. Journal of Neurology 262:6, pages 1407-1423.
Crossref
Crossref
Frank Cloutier, Alier Marrero, Colleen O’Connell & Pier Jr Morin. (2014) MicroRNAs as Potential Circulating Biomarkers for Amyotrophic Lateral Sclerosis. Journal of Molecular Neuroscience 56:1, pages 102-112.
Crossref
Crossref
Neta Zach, David L. Ennist, Albert A. Taylor, Hagit Alon, Alexander Sherman, Robert Kueffner, Jason Walker, Ervin Sinani, Igor Katsovskiy, Merit Cudkowicz & Melanie L. Leitner. (2015) Being PRO-ACTive: What can a Clinical Trial Database Reveal About ALS?. Neurotherapeutics 12:2, pages 417-423.
Crossref
Crossref
J. D. Beard & F. Kamel. (2014) Military Service, Deployments, and Exposures in Relation to Amyotrophic Lateral Sclerosis Etiology and Survival. Epidemiologic Reviews 37:1, pages 55-70.
Crossref
Crossref
Robert Küffner, Neta Zach, Raquel Norel, Johann Hawe, David Schoenfeld, Liuxia Wang, Guang Li, Lilly Fang, Lester Mackey, Orla Hardiman, Merit Cudkowicz, Alexander Sherman, Gokhan Ertaylan, Moritz Grosse-Wentrup, Torsten Hothorn, Jules van Ligtenberg, Jakob H Macke, Timm Meyer, Bernhard Schölkopf, Linh Tran, Rubio Vaughan, Gustavo Stolovitzky & Melanie L Leitner. (2014) Crowdsourced analysis of clinical trial data to predict amyotrophic lateral sclerosis progression. Nature Biotechnology 33:1, pages 51-57.
Crossref
Crossref
Young Ho Lee, Jae-Hoon Kim, Young Ho Seo, Sung Jae Choi, Jong Dae Ji & Gwan Gyu Song. (2014) Paraoxonase 1 Q192R and L55M polymorphisms and susceptibility to amyotrophic lateral sclerosis: a meta-analysis. Neurological Sciences 36:1, pages 11-20.
Crossref
Crossref
Ming-Dong Wang, James Gomes, Neil R. Cashman, Julian Little & Daniel Krewski. (2014) A Meta-Analysis of Observational Studies of the Association Between Chronic Occupational Exposure to Lead and Amyotrophic Lateral Sclerosis. Journal of Occupational & Environmental Medicine 56:12, pages 1235-1242.
Crossref
Crossref
Elpidio Maria Garzillo, Monica Lamberti, Giuliana Genovese, Paola Pedata, Daniela Feola, Nicola Sannolo, Luca Daniele, Francesca Trojsi, Maria Rosaria Monsurro & Nadia Miraglia. (2014) Blood Lead, Manganese, and Aluminum Levels in a Regional Italian Cohort of ALS Patients. Journal of Occupational & Environmental Medicine 56:10, pages 1062-1066.
Crossref
Crossref
Maria Teresa Baltazar, Ricardo Jorge Dinis-Oliveira, Maria de Lourdes Bastos, Aristidis M. Tsatsakis, José Alberto Duarte & Félix Carvalho. (2014) Pesticides exposure as etiological factors of Parkinson's disease and other neurodegenerative diseases—A mechanistic approach. Toxicology Letters 230:2, pages 85-103.
Crossref
Crossref
Yu Yu, Feng-Chiao Su, Brian C. Callaghan, Stephen A. Goutman, Stuart A. Batterman & Eva L. Feldman. (2014) Environmental Risk Factors and Amyotrophic Lateral Sclerosis (ALS): A Case-Control Study of ALS in Michigan. PLoS ONE 9:6, pages e101186.
Crossref
Crossref
Caroline M. Tanner, Samuel M. Goldman, G. Webster Ross & Stephen J. Grate. (2014) The disease intersection of susceptibility and exposure: Chemical exposures and neurodegenerative disease risk. Alzheimer's & Dementia 10:3S.
Crossref
Crossref
Susana PintoMamede de Carvalho. (2014) Breathing new life into treatment advances for respiratory failure in amyotrophic lateral sclerosis patients. Neurodegenerative Disease Management 4:1, pages 83-102.
Crossref
Crossref
Hyun Kang, Eun Shil Cha, Geun Joo Choi & Won Jin Lee. (2014) Amyotrophic Lateral Sclerosis and Agricultural Environments: A Systematic Review. Journal of Korean Medical Science 29:12, pages 1610.
Crossref
Crossref
Angela M. Malek, Aaron Barchowsky, Robert Bowser, Terry Heiman-Patterson, David Lacomis, Sandeep Rana, Ada Youk, David Stickler, Daniel T. Lackland & Evelyn O. Talbott. (2014) Environmental and Occupational Risk Factors for Amyotrophic Lateral Sclerosis: A Case-Control Study. Neurodegenerative Diseases 14:1, pages 31-38.
Crossref
Crossref
Francesca Trojsi, Maria Monsurrò & Gioacchino Tedeschi. (2013) Exposure to Environmental Toxicants and Pathogenesis of Amyotrophic Lateral Sclerosis: State of the Art and Research Perspectives. International Journal of Molecular Sciences 14:8, pages 15286-15311.
Crossref
Crossref
S. Alvarez, A. Calin, K.S. Graffmo, M. Moldovan & C. Krarup. (2013) Peripheral motor axons of SOD1G127X mutant mice are susceptible to activity-dependent degeneration. Neuroscience 241, pages 239-249.
Crossref
Crossref
Sara Mostafalou & Mohammad Abdollahi. (2013) Pesticides and human chronic diseases: Evidences, mechanisms, and perspectives. Toxicology and Applied Pharmacology 268:2, pages 157-177.
Crossref
Crossref
Guilherme Fregonezi, Palomma Russelly Saldanha Araújo, Tathiana Lindemberg Ferreira Macêdo, Mario Emilio Dourado Junior, Vanessa Regiane Resqueti & Armele de Fátima Dornelas de Andrade. (2013) Monitoring respiratory muscle strength assists in early diagnosis of respiratory dysfunction as opposed to the isolated use of pulmonary function evaluation in amyotrophic lateral sclerosis. Arquivos de Neuro-Psiquiatria 71:3, pages 146-152.
Crossref
Crossref
E. Pupillo, P. Messina, G. Logroscino, S. Zoccolella, A. Chiò, A. Calvo, M. Corbo, C. Lunetta, A. Micheli, A. Millul, E. Vitelli & E. Beghi. (2012) Trauma and amyotrophic lateral sclerosis: a case–control study from a population‐based registry. European Journal of Neurology 19:12, pages 1509-1517.
Crossref
Crossref
David A. Jett. (2011) Neurotoxic Pesticides and Neurologic Effects. Neurologic Clinics 29:3, pages 667-677.
Crossref
Crossref
A. Jawaid, M. Poon, A. M. Strutt, L. K. Rice, E. J. McDowell, A. R. Salamone, S. U. Qureshi, E. Simpson, S. H. Appel, M. K. York & P. E. Schulz. (2011) Does apolipoprotein E genotype modify the clinical expression of ALS?. European Journal of Neurology 18:4, pages 618-624.
Crossref
Crossref
A. Jawaid, A. R. Salamone, A. M. Strutt, S. B. Murthy, M. Wheaton, E. J. McDowell, E. Simpson, S. H. Appel, M. K. York & P. E. Schulz. (2010) ALS disease onset may occur later in patients with pre‐morbid diabetes mellitus. European Journal of Neurology 17:5, pages 733-739.
Crossref
Crossref
Alain Furby, Katell Beauvais, Ivan Kolev, Jean-Gérard Rivain & Véronique Sébille. (2009) Rural environment and risk factors of amyotrophic lateral sclerosis: a case–control study. Journal of Neurology 257:5, pages 792-798.
Crossref
Crossref
Isabel Carreras, Sinan Yuruker, Nurgul Aytan, Lokman Hossain, Ji-Kyung Choi, Bruce G. Jenkins, Neil W. Kowall & Alpaslan Dedeoglu. (2010) Moderate exercise delays the motor performance decline in a transgenic model of ALS. Brain Research 1313, pages 192-201.
Crossref
Crossref
Carmel Armon. (2009) Smoking may be considered an established risk factor for sporadic ALS. Neurology 73:20, pages 1693-1698.
Crossref
Crossref
Patrick A. Dion, Hussein Daoud & Guy A. Rouleau. (2009) Genetics of motor neuron disorders: new insights into pathogenic mechanisms. Nature Reviews Genetics 10:11, pages 769-782.
Crossref
Crossref
Colin K. Franz, Eric T. Quach, Christina A. Krudy, Thais Federici, Michele A. Kliem, Brooke R. Snyder, Bethwel Raore & Nicholas M. Boulis. (2009) A Conditioning Lesion Provides Selective Protection in a Rat Model of Amyotrophic Lateral Sclerosis. PLoS ONE 4:10, pages e7357.
Crossref
Crossref
Frank O. Johnson & William D. Atchison. (2009) The role of environmental mercury, lead and pesticide exposure in development of amyotrophic lateral sclerosis. NeuroToxicology 30:5, pages 761-765.
Crossref
Crossref
M.-H. Soriani & C. Desnuelle. (2009) Épidémiologie de la SLA. Revue Neurologique 165:8-9, pages 627-640.
Crossref
Crossref
A. -M. Wills, S. Cronin, A. Slowik, D. Kasperaviciute, M. A. Van Es, J. M. Morahan, P. N. Valdmanis, V. Meininger, J. Melki, C. E. Shaw, G. A. Rouleau, E.M.C. Fisher, P. J. Shaw, K. E. Morrison, R. Pamphlett, L. H. Van den Berg, D. A. Figlewicz, P. M. Andersen, A. Al-Chalabi, O. Hardiman, S. Purcell, J. E. Landers & R. H. BrownJrJr. (2009) A large-scale international meta-analysis of paraoxonase gene polymorphisms in sporadic ALS. Neurology 73:1, pages 16-24.
Crossref
Crossref
Ari NowacekLisa M KosloskiHoward E Gendelman. (2009) Neurodegenerative disorders and nanoformulated drug development. Nanomedicine 4:5, pages 541-555.
Crossref
Crossref
David A. Jett & Jason R. Richardson. 2009. Clinical Neurotoxicology. Clinical Neurotoxicology
491
499
.
Mary E. McCrate & Brian K. Kaspar. (2008) Physical Activity and Neuroprotection in Amyotrophic Lateral Sclerosis. NeuroMolecular Medicine 10:2, pages 108-117.
Crossref
Crossref
A. -M. WillsJ. E. LandersH. ZhangR. J. RichterA. J. CaraganisM. E. CudkowiczC. E. FurlongR. H. BrownJrJr. (2008) Paraoxonase 1 (PON1) organophosphate hydrolysis is not reduced in ALS. Neurology 70:12, pages 929-934.
Crossref
Crossref
Jacqueline Montes, Caterina Bendotti, Massimo Tortarolo, Cristina Cheroni, Hussein Hallak, Zipora Speiser, Sari Goren, Eran Blaugrund & Paul H. Gordon. 2008. Animal and Translational Models for CNS Drug Discovery. Animal and Translational Models for CNS Drug Discovery
267
310
.
Heather D. Durham. 2008. Heat Shock Proteins and the Brain: Implications for Neurodegenerative Diseases and Neuroprotection. Heat Shock Proteins and the Brain: Implications for Neurodegenerative Diseases and Neuroprotection
203
221
.
J. Gil, B. Funalot, F. Torny, M. Lacoste & P. Couratier. (2007) Facteurs de risque exogènes de la sclérose latérale amyotrophique sporadique. Revue Neurologique 163:11, pages 1021-1030.
Crossref
Crossref
A.V. Kabanov & H.E. Gendelman. (2007) Nanomedicine in the diagnosis and therapy of neurodegenerative disorders. Progress in Polymer Science 32:8-9, pages 1054-1082.
Crossref
Crossref
JD Mitchell & GD Borasio. (2007) Amyotrophic lateral sclerosis. The Lancet 369:9578, pages 2031-2041.
Crossref
Crossref